| A high frequency of sequence alterations is due to formalin fixation of archival specimens C Williams, F Pontén, C Moberg, P Söderkvist, M Uhlén, J Pontén, ... The American journal of pathology 155 (5), 1467-1471, 1999 | 625 | 1999 |
| A comprehensive pan-cancer molecular study of gynecologic and breast cancers AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ... Cancer cell 33 (4), 690-705. e9, 2018 | 617 | 2018 |
| A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells C Williams, K Edvardsson, SA Lewandowski, A Ström, JÅ Gustafsson Oncogene 27 (7), 1019-1032, 2008 | 329 | 2008 |
| Tumor repressive functions of estrogen receptor β in SW480 colon cancer cells J Hartman, K Edvardsson, K Lindberg, C Zhao, C Williams, A Ström, ... Cancer research 69 (15), 6100-6106, 2009 | 261 | 2009 |
| Insufficient antibody validation challenges oestrogen receptor beta research S Andersson, M Sundberg, N Pristovsek, A Ibrahim, P Jonsson, B Katona, ... Nature communications 8 (1), 15840, 2017 | 257 | 2017 |
| Estrogen receptor signaling during vertebrate development M Bondesson, R Hao, CY Lin, C Williams, JÅ Gustafsson Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1849 (2), 142-151, 2015 | 238 | 2015 |
| Estrogen receptor beta as target for colorectal cancer prevention C Williams, A DiLeo, Y Niv, JÅ Gustafsson Cancer letters 372 (1), 48-56, 2016 | 190 | 2016 |
| A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ... Cell systems 7 (4), 422-437. e7, 2018 | 160 | 2018 |
| PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer G Ling, A Ahmadian, Å Persson, AB Undén, G Afink, C Williams, M Uhlén, ... Oncogene 20 (53), 7770-7778, 2001 | 160 | 2001 |
| Benchmarking virus concentration methods for quantification of SARS-CoV-2 in raw wastewater MH Jafferali, K Khatami, M Atasoy, M Birgersson, C Williams, Z Cetecioglu Science of The Total Environment 755, 142939, 2021 | 148 | 2021 |
| Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3 P Dey, P Jonsson, J Hartman, C Williams, A Ström, JÅ Gustafsson Molecular endocrinology 26 (12), 1991-2003, 2012 | 148 | 2012 |
| Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells K Edvardsson, A Ström, P Jonsson, JÅ Gustafsson, C Williams Molecular endocrinology 25 (6), 969-979, 2011 | 148 | 2011 |
| Genome-wide profiling of AP-1–regulated transcription provides insights into the invasiveness of triple-negative breast cancer C Zhao, Y Qiao, P Jonsson, J Wang, L Xu, P Rouhi, I Sinha, Y Cao, ... Cancer research 74 (14), 3983-3994, 2014 | 147 | 2014 |
| Oestrogen receptors in breast cancer: basic mechanisms and clinical implications C Williams, CY Lin Ecancermedicalscience 7, 2013 | 147 | 2013 |
| Colitis‐induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity A Ibrahim, LW Hugerth, L Hases, A Saxena, M Seifert, Q Thomas, ... International journal of cancer 144 (12), 3086-3098, 2019 | 137 | 2019 |
| Molecular pathology in basal cell cancer with p53 as a genetic marker Pontén F, Berg C, Ahmadian A, Ren ZP, Nistér M, Lundeberg J, Uhlén M, Pontén J Oncogene 15 (9), 1059-67, 1997 | 125 | 1997 |
| miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene E Tsouko, J Wang, DE Frigo, E Aydoğdu, C Williams Carcinogenesis 36 (9), 1051-1060, 2015 | 123 | 2015 |
| miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer J Wang, E Tsouko, P Jonsson, J Bergh, J Hartman, E Aydogdu, ... Molecular oncology 8 (8), 1690-1702, 2014 | 119 | 2014 |
| Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. ZP Ren, A Ahmadian, F Ponten, M Nistér, C Berg, J Lundeberg, M Uhlen, ... The American journal of pathology 150 (5), 1791, 1997 | 105 | 1997 |
| Liver× receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism T Nguyen-Vu, LL Vedin, K Liu, P Jonsson, JZ Lin, NR Candelaria, ... Breast cancer research 15, 1-12, 2013 | 103 | 2013 |
Johan HartmanDept of Oncology-Pathology, Karolinska InstitutetVahvistettu sähköpostiosoite verkkotunnuksessa ki.se